BIIB vs MREO · P/E 21, rev $9.89B vs $48.7M cap
Biogen Inc (BIIB) versus Mereo BioPharma Group PLC ADR (MREO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. MREO currently screens at market cap $48.7M.
Not investment advice. Open the BIIB and MREO stock pages for the full models.
Not investment advice.